Pharma and Healthcare Dealtracker: Q3 2026
India’s pharma and healthcare sector remained active in Q3 2026 as organisations advanced consolidation, regional expansion and capability-building agendas.
For more updates follow Grant Thornton Bharat on WhatsApp

Sell side - Deal advisory services for divestments of businesses, disposal of strategic assets, identifying strategic partners and Joint Ventures
As one of the leading M&A advisory firms in India, our team of experienced professionals across sectors can support you in your strategic objectives, including divestments or forming joint ventures. With our global presence, we can leverage upon our local and international network offices to reach out to business houses, conglomerates, buy-out funds and other corporates to drive value for the client.
As an M&A advisory firm, our objective is to drive forward the transaction and conclude it timely and effectively, while maximising value creation for our clients.
As end-to-end deal advisors, we will be involved at every step required for the closure of a successful deal, including the following:
Project managing the complete deal process by acting as a single point of contact for our clients.

With a strong domestic and global presence and expertise in cross-border transactions, we are best placed to manage M&A transactions with overseas involvement in searching for an international or a domestic company as an acquisition target that is the best strategic fit for your business.
As an M&A advisory firm, our objective will be to drive forward the transaction and conclude it timely and effectively.
We will be involved at every step required for the successful closure of the transaction, including the following:
Our highly experienced team of professionals spread across sectors will assist you in raising funds (debt and equity) for growth capital, leveraged buyouts, acquisition financing, etc.
We have worked with a range of financial institutions, including banks, NBFCs, private equity and venture capital funds. We have the ability to reach out to global private equity and venture capital funds to attract quality growth capital.
As advisors, our objective will be to drive forward the transaction and conclude it timely and effectively, unlocking maximum value for stakeholders.
We will be involved at every step required for the successful closure of the transaction, including the following:

Deals are getting more complex as valuation gaps widen, with contingent consideration emerging as a key tool to align expectations and strategic goals.

Unlock growth with Grant Thornton Bharat's Digital Natives solutions. Customised support for tech-driven companies in healthcare, gaming, and more.
India’s pharma and healthcare sector remained active in Q3 2026 as organisations advanced consolidation, regional expansion and capability-building agendas.
The consumer and retail sector saw investors become more selective in Q3 2026, with capital favouring differentiated brands, category leaders and scalable business models. Public markets emerged as an important funding avenue, while premiumisation remained a key investment theme across consumer segments. The Q3 2026 edition of the Consumer and Retail Dealtracker analyses deal activity across M&A, private equity, venture capital and public markets, and highlights the trends influencing investment decisions across the sector.
India’s real estate sector continued to attract investor interest in Q3 2026, driven by domestic participation, private equity investments and demand for income-generating assets. Investors remained focused on quality opportunities across key segments, supporting transaction activity despite a selective investment environment.